On March 4, the co-chairs of the European Parliament Intergroup (IG) on Cancer & Rare Diseases hosted the official launch of its 2025 Annual Workplan. This event marks a pivotal moment in shaping Europe’s discourse on health policy, as legislators, policymakers, and key stakeholders gathered to discuss the priorities of the IG identified for this year and beyond. The IG, led by key voices in health policy across the European Parliament groups, is a sign of the continued focus on cancer and rare diseases on the EU agenda.   

The European Cancer Organisation (ECO), EURORDIS-Rare Diseases Europe, and the European Society for Paediatric Oncology (SIOPE) welcome a major initiative from the European Parliament's Conference of Presidents: the creation of a new ‘Intergroup on Cancer & Rare Diseases’ for the 2024-2029 legislature.